Chartsonlygoup's future update (it'll live): tomwong.xyz/stock-status/

What is ALXN's Pretax Income (Earnings) Margin?

  Alexion Pharmaceuticals Inc ( ALXN ) |
2002 - 2021 (20 years)

Pretax Income (Earnings) Margin is 
0.8 (1Y -10.3% )

ALXN Stock Price & Pretax Income (Earnings) Margin

Pretax Income (Earnings) Margin for ALXN competitors.
CELG GILD REGN VRTX BIIB AGIO RARE IONS QGEN XON
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Pretax Income (Earnings) Margin

chevron_right 2021 0.37 -1.0x *
( -25.4% / year avg)
chevron_left 2002 -129.51
vertical_align_top Peak 1.54 +1.0x *
vertical_align_bottom Bottom -499.3
arrow_drop_up # Up Years 10 10 of 20
years up.
arrow_drop_down # Down Years 10
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • ALXN's stock price has rallied +4,601% from $2.31 in 2002 , or -45.0x faster than it's pretax income (earnings) margin over the same period.
  • If ALXN shrinks it's stock at the same rate as it's pretax income (earnings) margin (-25.4%/year) , it's stock price will shrink +5.34% and hit $5.8 over the next 10 years.
  • ALXN's stock price has gone up 4 of the 10 years (+40%) it's pretax income (earnings) margin were also up.
* A modified method (see: here) is used to calculate changes that involve negative numbers.
  • ALXN Historical Pretax Income (Earnings) Margin Table

    * A modified method (see: here) is used to calculate changes that involve negative numbers.
    Year Pretax Income (Earnings) Margin YoY % Change* Stock Price YoY % Change (Stock Price)
    4/1/2021 0.37 -1.8% $108.72 -9.3%
    4/1/2020 0.38 -70.6% $119.9 5.5%
    4/1/2019 1.29 214.1% $113.68 -2.1%
    4/1/2018 0.41 -36.3% $116.13 18.5%
    4/1/2017 0.64 19.6% $98.03 -30.4%
    4/1/2016 0.54 -46.8% $140.8 -21.9%
    4/1/2015 1.01 -34.4% $180.37 2.0%
    4/1/2014 1.54 11.0% $176.8 91.9%
    4/1/2013 1.39 0.5% $92.14 -0.8%
    4/1/2012 1.38 23.6% $92.86 88.2%
    4/1/2011 1.12 9.8% $49.34 81.5%
    4/1/2010 1.02 17.3% $27.18 44.4%
    4/1/2009 0.87 -119.7% $18.83 27.0%
    4/1/2008 -4.4 -98.0% $14.82 37.1%
    4/1/2007 -222.17 -39.5% $10.81 22.1%
    4/1/2006 -367.36 -26.4% $8.86 63.5%
    4/1/2005 -499.3 8.5% $5.42 -8.8%
    4/1/2004 -460.39 -5.7% $5.94 80.8%
    4/1/2003 -488.18 276.9% $3.29 -28.8%
    4/1/2002 -129.51 - $4.62 -

  • About
    Industry: Biotechnology
    Sector: Healthcare
    Country: US
    IPO Date: 2/1/1996
    Stonk Exchange: NASDAQ
    • Alexion Pharmaceuticals, Inc
    • is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.
    • The company is headquartered in Boston, Massachusetts and currently employs 2,656 full-time employees.
    • The firm is focused on the development and commercialization of therapeutic products.
    • The firm's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).
    • The firm's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous).
    • Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS).
    • PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system.
    • Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP).
    • Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D).
    • The company is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.

  • Pretax Earnings Margin (also known as income before tax ratio) is a financial accounting tool used to measure the operating efficiency of a company. It is a ratio that tells us the percentage of sales that has turned into profits or, in other words, how many cents of profit the business has generated for each dollar of sale before deducting taxes. The pretax profit margin is widely used to compare the profitability of businesses within the same industry.

    For more detailed definitions, please see Investopedia.